[
  {
    "ts": null,
    "headline": "Danaher (DHR): Evaluating Valuation After AI Pathology Launch and Pharma Sector Boost",
    "summary": "Danaher (NYSE:DHR) shares have jumped following two important developments. Its Leica Biosystems unit unveiled new AI-powered digital pathology solutions, and a favorable shift in US pharmaceutical tariffs is energizing the broader sector. See our latest analysis for Danaher. Momentum seems to be swinging back in Danaher’s favor, with strong sector tailwinds and new AI-driven products helping the company rebound after a lackluster stretch. While the 1-year total shareholder return has...",
    "url": "https://finnhub.io/api/news?id=fd930cced10076d0792660ffc647b234d1b9b4a8f7f717d09aad3f692aa9b94d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759423160,
      "headline": "Danaher (DHR): Evaluating Valuation After AI Pathology Launch and Pharma Sector Boost",
      "id": 136960245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher (NYSE:DHR) shares have jumped following two important developments. Its Leica Biosystems unit unveiled new AI-powered digital pathology solutions, and a favorable shift in US pharmaceutical tariffs is energizing the broader sector. See our latest analysis for Danaher. Momentum seems to be swinging back in Danaher’s favor, with strong sector tailwinds and new AI-driven products helping the company rebound after a lackluster stretch. While the 1-year total shareholder return has...",
      "url": "https://finnhub.io/api/news?id=fd930cced10076d0792660ffc647b234d1b9b4a8f7f717d09aad3f692aa9b94d"
    }
  },
  {
    "ts": null,
    "headline": "BLCO vs. DHR: Which Stock Should Value Investors Buy Now?",
    "summary": "BLCO vs. DHR: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=83f716a200b40be0e0b87bdf918cfc141fd69ecbda65f0b1673de59239385d64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759419602,
      "headline": "BLCO vs. DHR: Which Stock Should Value Investors Buy Now?",
      "id": 136960246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "BLCO vs. DHR: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=83f716a200b40be0e0b87bdf918cfc141fd69ecbda65f0b1673de59239385d64"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corporation (DHR) To Release FQ3 Results on October 21",
    "summary": "Danaher Corporation (NYSE:DHR) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 23, Danaher Corporation (NYSE:DHR) announced that it will release its fiscal third-quarter results on October 21, 2025. The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered a revenue of $5.94 billion, […]",
    "url": "https://finnhub.io/api/news?id=22cec7393eb6366b8f4848e7845e42722d85f7abeb418c0c6c08df33395a5e9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759388134,
      "headline": "Danaher Corporation (DHR) To Release FQ3 Results on October 21",
      "id": 136955477,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE:DHR) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 23, Danaher Corporation (NYSE:DHR) announced that it will release its fiscal third-quarter results on October 21, 2025. The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered a revenue of $5.94 billion, […]",
      "url": "https://finnhub.io/api/news?id=22cec7393eb6366b8f4848e7845e42722d85f7abeb418c0c6c08df33395a5e9d"
    }
  }
]